Hot Stocks

Hot stocks are not about hype. They emerge when powerful themes, policy shifts, and capital flows converge. InvestorPlace analysts track fast-moving market narratives, especially in technology, AI, and infrastructure, to identify stocks drawing outsized attention and explain what is really driving those moves.

Memo to Marissa Mayer, Re: Turnarounds

By Marc Bastow, InvestorPlace Assistant Editor
Turnarounds are exceedingly tough to pull off -- but not quite impossible. For inspiration, Yahoo's new(est) CEO should look no further than these three examples.

Even a Profitable BofA Shows Banking’s Risks

By Dan Burrows, InvestorPlace Feature Writer
Financials are propping up earnings season -- thanks to easy comparisons. But they have miles to go and many headwinds to overcome before returning to health.

Stanley Black & Decker Falls Short of Q2 Expectations

By InvestorPlace Staff
Stanley Black & Decker announced lower second-earnings that widely missed estimates Wednesday, but SWK shares still were up in midday trading.

Wynn Earnings Don’t Tell The Whole Story

By Lawrence Meyers, InvestorPlace Contributor
Earnings in resort and gaming fluctuate, but a visit to Las Vegas has made the quality of Wynn's properties even more clear. Here's how to play the stock.

How Amazon.com Will Kill Costco

By Jeff Reeves
If you can find it at Costco, chances are you can find it at Amazon. Here's why the online site will be the big-box retailer of the future -- and KO Costco.

Earnings Outyell Bernanke — Tuesday IP Market Recap

By Marc Bastow, InvestorPlace Assistant Editor
Despite non-comments by Fed chairman Ben Bernanke, markets finished the day in the black, led by earnings-driven gains in Coca-Cola, Goldman and others.

Gold, Silver Slip After Hopeful Start Tuesday

By Angela Nazworth, InvestorPlace Writer
Gold and silver trading looked hopeful earlier Tuesday, but slipped after Federal Chairman Ben Bernanke gave his weekly economic address.

The Crux of Marissa Mayer’s Problem at Yahoo

By Jonathan Berr, InvestorPlace Contributor
Her content strategy will be the key decision -- and it's tough. Does she expand Yahoo's original content to woo advertisers at the risk of alienating partners?

Berkshire Hathaway’s Premium: Confidence

By Marc Bastow, InvestorPlace Assistant Editor
Berkshire Hathaway shares have marched to 52-week highs as investors continue to believe in the succession preparation efforts of Warren Buffett.

Coca-Cola Is Starting to Sweat

By Jeff Reeves
Rising costs weighed on Coca-Cola's bottom line for Q2, and while KO still looks good down the road, short-term headwinds shouldn't be ignored.

Shorts Are Piling Onto These 3 Companies

By Tom Taulli, InvestorPlace Contributor
A shaky earnings season could be good news for the shorts. Here are three companies really getting the stink-eye from investors right now.

Grading 6 Defense Contractors After the Farnborough Air Show

By Susan J. Aluise, Aviation, Auto & Transportation Writer
Looming defense cuts mean investors have to chose carefully. Here's how the sector's top players stack up now that the results of this year's air show are in.

Cure TV’s Nuttiness With a la Carte Pricing

By Jonathan Berr, InvestorPlace Contributor
Industry battles over carriage fees, such as the Dish-Viacom brawl, mask a bigger issue. Why should consumers pay for channels they don't want?

9 Biotech Buyout Players to Watch

By Jeff Reeves
The deal between Human Genome Sciences and GlaxoSmithKline is just the most recent of big pharma buyouts -- and these biotech players could be next.

Retail Results Spoil the Day — Monday’s IP Market Recap

By Marc Bastow, InvestorPlace Assistant Editor
A disappointing retail report and mixed results for Citigroup's second quarter weighed on markets Monday, though M&A news sparked life into pharma.

Gold, Silver Lack Luster on Monday

By Angela Nazworth, InvestorPlace Writer
Gold futures traded flat and silver showed marginal losses Monday as investors wait for Bernanke to speak this week in Washington.

HGSI Holdout Proves Profitable — for Bagels

By Marc Bastow, InvestorPlace Assistant Editor
Joint pharmaceutical developers Human Genome and GlaxoSmithKline agreed to a sweetened $14.25/share offer for HGSI, cheering Rockville-area diners.

Citigroup: Too Big to Grow?

By Dan Burrows, InvestorPlace Feature Writer
Yes, its balance sheet is stronger, and the worst may be over. But the bank's global sprawl is hampering revenue and profits, and it's hard to see past that.

GlaxoSmithKline to Pay $3.6B for Human Genome Sciences

By Christopher Freeburn, InvestorPlace Writer
GlaxoSmithKline will pay $14.25 a share, a total of $3.6 billion, to acquire its long-term research partner Human Genome Sciences.
Load More Articles